(Q33186052)

23 July 2017

1 reference

title

Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy (English)

1 reference

23 July 2017

1

Alexander M M Eggermont

1 reference

23 July 2017

Timo L M ten Hagen

2

1 reference

23 July 2017

publication date

1 March 2003

1 reference

23 July 2017

published in

Current Oncology Reports

1 reference

23 July 2017

volume

5

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

79-80

1 reference

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

23 July 2017

cites work

1 reference

12 December 2020

Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats

1 reference

12 December 2020

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

12 December 2020

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

12 December 2020

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

12 December 2020

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver

1 reference

12 December 2020

TNF is here to stay--revisited

1 reference

12 December 2020

10.1007/S11912-003-0091-X

Identifiers

DOI

1 reference

Dimensions Publication ID

23 July 2017

1011668612

0 references

1 reference